Vaginal micronised progesterone soft gel capsule for the treatment of threatened miscarriage

Description

In this Product Explainer, Professor of Obstetrics & Gynaecology, William Ledger explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Jo-Ann See

Dr Jo-Ann See

Management of Acne in Teens

Dr Robert Hungerford

Dr Robert Hungerford

An Update on Heart Failure in General Practice

A/Prof Daryl Cheng

A/Prof Daryl Cheng

Invasive Pneumococcal Disease – What GPs Need to Know

A/Prof Yvonne Zissiadis

A/Prof Yvonne Zissiadis

Innovations in Breast Radiation

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Emeritus Prof William Ledger

expert

Emeritus Prof William Ledger

Fertility Specialist; City Fertility Sydney, Emeritus Professor of Obstetrics and Gynaecology; School of Medicine, University of New South Wales

Date published: 8 August 2023